Search clinical trials for: Influenza vaccine

Total 6448 results

Beijing Chaoyang District Centre for Disease Control...

Unknown

Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older

Influenza
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)

Influenza

France
National Institute of Allergy and Infectious Diseases...

Completed

H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults

Influenza

United States
Dalhousie University
Mount Sinai Hospital, Canada; IWK Health Centre; MCM Vaccines B.V.

Completed

Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine

Influenza

Canada
Emory University
Defense Advanced Research Projects Agency

Recruiting

Systems Biological Assessment of the Durability of Vaccine Responses (DARPASB)

Vaccine Response

United States
Takeda

Completed

A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects

Pandemic Influenza Prevention

Japan
Seqirus

Completed

A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers

Influenza

United Kingdom
University of Rochester
National Institutes of Health (NIH)

Completed

Effects of Age on Response to the 2009 H1N1 Virus Vaccine

2009 H1N1 Influenza Virus

United States
Institute of Cardiology, Warsaw, Poland
Solvay Pharmaceuticals

Completed

Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study

Coronary Artery Disease

Poland
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 Years

Influenza

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age (QHD04)

Influenza

United States, Canada
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Seroprotection

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients

Influenza

United States
Rebecca Cox
Haukeland University Hospital; European Commission

Completed

Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults (PANFLUVAC)

Healthy | Influenza

Norway
Makerere University

Unknown

Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial (PREST)

Preventing Stroke in Sickle Cell Anaemia

Uganda
Rockefeller University

Terminated

Impact of Metabolic Syndrome on Flu Vaccine Efficacy

Metabolic Syndrome | Immune Deficiency

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Influenza

Finland
Vanderbilt University
Centers for Disease Control and Prevention; Marshfield Clinic Research Foundation

Completed

Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults

Aging
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Influenza Disease

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Influenza

Italy
Federico Martinón Torres

Recruiting

HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia

Influenza

Spain
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Bone Marrow and Peripheral Blood Immune Responses Study

Influenza

United States
Finnish Institute for Health and Welfare
Hospital District of Helsinki and Uusimaa

Recruiting

Immune Responses in Health Care Personnel

Influenza

Finland
Stony Brook University
University of North Carolina, Chapel Hill

Completed

Flu Vaccine Response in Patients on Biologic Therapies

Inflammatory Bowel Diseases | Immune Complex Diseases | Rheumatologic Disorder

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - T Cells

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Antibody

Influenza

United States
Sungkyunkwan University
Government-wide R&D Fund project for infectious disease research (GFID)

Unknown

Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy

Pregnancy Related | Influenza Virus Vaccine Adverse Reaction
University of Wisconsin, Madison

Completed

Immunological Consequences of Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Fundación Pública Andaluza Progreso y Salud
Spanish Network for Research in Infectious Diseases

Completed

Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination (TraNsgripe)

Infection in Solid Organ Transplant Recipients

Spain
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects

Influenza Disease

Italy
Tel-Aviv Sourasky Medical Center

Unknown

Influenza Vaccination in Patients With Scleroderma

Influenza Vaccine in Scleroderma

Israel
Novartis
Novartis Vaccines; Chiron s.r.l. Beijing Representative Office

Completed

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

Influenza

China
Pfizer

Completed

Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.

PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE

United States
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Safety Issues

Indonesia
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Coronavirus Disease 2019

China
University of California, Los Angeles
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Pediatric Second Influenza Dose Portal Reminder Recall

Respiratory Tract Infections | Influenza

United States
VaxInnate Corporation

Unknown

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

Influenza

Australia
Beijing Chaoyang District Centre for Disease Control...

Completed

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

Quadrivalent Influenza Virus Vaccine

China
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

Italy, Belgium, France, Lithuania
Sanofi

Completed

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Influenza | Orthomyxoviridae Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Avian Influenza | Immunisation

United States
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions

Influenza, Human

Germany
Oswaldo Cruz Foundation
Ministry of Health, Brazil

Completed

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults (VIP-H1N1)

HIV Infection

Brazil
Sanofi Pasteur, a Sanofi Company

Completed

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.

Influenza

United States
Ology Bioservices

Completed

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Influenza | Avian Influenza

Austria, Finland
Sanofi Pasteur, a Sanofi Company

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

Czech Republic, Lithuania, Belgium
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Prevention | Pandemic Influenza

3

Subscribe